Skip to main content
. 2022 Jan 5;3(1):4–11. doi: 10.1302/2633-1462.31.BJO-2021-0166.R1

Table I.

Demographics and patients’ characteristics.

Variable Group A (n = 86) Group B (n = 172) p-value
Mean BMI, kg/m2 (SD; range) 42.33 (2.06; 40.00 to 49.12) 24.97 (2.29; 20.00 to 29.92) < 0.001*
Sex, M:F; n (%) 39 (45.3):47 (54.7) 78 (45.3):94 (54.7) N/A
Mean age, yrs (SD; range) 64.90 (10.42; 44 to 84) 64.67 (9.53; 42 to 84) 0.858*
Mean follow-up, yrs (SD) 5.29 (1.79) 5.24 (1.77) 0.843
Hypertension, n (%) 48 (55.8) 83 (48.3) 0.291
Atrial fibrillation, n (%) 11 (12.7) 7 (4) 0.017
Diabetes mellitus 27 (31.4) 14 (8.1) < 0.001
Coronary artery disease, n (%) 3 (3.5) 5 (2.9) 1.000
ESRD, n (%) 2 (2.3) 0 (0) 0.110
ASA score, n (%)
1 0 (0) 48 (27.9) < 0.001
2 0 (0) 113 (65.7) < 0.001
3 84 (97.6) 11 (6.3) < 0.001
4 2 (2.3) 0 (0) 0.110

Group A = patients with BMI ≥ 40 kg/m2

Group B = patients with BMI < 30 kg/m2

*

Independent-samples t-test

Mann-Whitney U test

Fisher's exact test

ASA, American Society of Anesthesiologists; ESRD, end-stage renal disease; Group A, morbidly obese; Group B, nonobese; N/A, not applicable; SD, standard deviation.